“Our market share of various products ranges from 5% to 40% but as a total share we will be happy to achieve 10% of medical technology industry in the next 5 years’ time.”

Q. Trivitron Medical Systems already enjoys a place of pride among the top five medical technology companies of India. What is your vision regarding Trivitron’s brand-building in the long term?

We want Trivitron to be a globally recognised medical technology brand standing for quality and innovation with strong customer relationships in the areas we are present. For this we will do sustained campaigns and ensure we live up to the promises we communicate through our branding campaign.

Q. The market for medical devices and equipment in India is estimated to reach nearly US$ 5 billion by 2012. What share of the market do you hope to capture by next 3-5 years and which segments do you target in particular?

Our market share of various products ranges from 5% to 40% but as a total share we will be happy to achieve 10% of medical technology industry in the next 5 years’ time.  As the leading and the largest medical technology company of Indian origin we hope we can achieve our ambition of reaching 10% of market share of the industry by offering a comprehensive range of medical technology products and solutions.

Q. What are your plans for tapping the overseas market “ particularly places like Singapore, Malaysia, Thailand, Philippines and the US and Europe?

Trivitron already operates in the Middle East territories through a joint venture company Star Trivitron, which is based in Dubai Healthcare City.  Apart from UAE the JV is focusing on establishing its presence in Oman, Qatar, Saudi Arabia, Kuwait and Middle Eastern/North African countries.  Trivitron is also looking at establishing its presence in Africa by creating a hub in South Africa and creating a presence in South East Asia by creating a hub in Thailand and Vietnam. We also hope to become a contract-manufacturing partner for the US, European and Japanese companies once Trivitron Medical Technology Park becomes operational in the year 2009.

Q. China already has a strong base in medical equipment manufacturing, along with a few good brand names originating from the country. Do you think there is any competitive threat for Indian manufacturers?

China is already way ahead of India in medical technology manufacturing and India has a lot of catching up to do before it becomes a potential threat to China. Chinas’ Medical Technology industry is estimated to be over US$ 12 billion, with US$ 6 billion of exports; but with the abundance of manpower, research and development base and the growing IT/biotech industry, India can definitely become a viable alternative to China for medical technology.

Q. What do you think are the existing bottlenecks and hurdles for the medical devices industry in the context of the current policy environment? What is your wish list from the government to facilitate the growth of this industry?

Present import policies of the Government of India for medical technology industry is quite lopsided and it favours trading rather than manufacturing. The inverted duty impact of this industry is also very significant making trading much more attractive than manufacturing. Simplified tariff structure in which there is a clear distinction between raw materials/component imports to finished good imports will help indigenous manufacturing initiatives. Also, the government should look at specific schemes to promote medical technology manufacturing by creating medical technology parks on the lines of software technology parks.

“Trivitron’s proposed Medical Technology Park in Chennai is going to be the first of its kind in the country and will attract investments to the tune of INR 250 crores in Phase -1.”

Q. Trivitron’s proposed medical technology park near Chennai is going to be the first of its kind in the country. What is the total budget outlay for this initiative? What will be some of the most salient features of this park and what is the planned manufacturing capacity to be achieved on completion?

Trivitron’s proposed Medical Technology Park in Chennai is going to be the first of its kind in the country and will attract investments to the tune of INR 250 crores in phase -1. This park will bring a cluster of manufacturers who are Trivitron’s present partners, under one roof; sharing common infrastructure and shared resources wherever possible. This manufacturing park should be able to produce medical technology products to the tune of INR 500 cr in the next 3 years.

Q. Trivitron had earlier announced its ambition to achieve INR 1000 crore turnover in the next 3 years. What are your strategies for achieving such phenomenal growth?

Trivitron should have a turnover of over INR 200 cr. this financial year and with contributions from manufacturing through acquisitions, technology park initiatives and international expansion of trading activities. Trivitron hope to achieve INR 1000 cr turnover the next 3 years.

Q. What are your plans in terms of adding new product/service lines to Trivitron in the near future? Do you wish to venture into healthcare services and/or the pharma sector?

Trivitron has opened a Healthcare IT division offering comprehensive solution of IT hardware and software to healthcare institutions. The service offering will include Hospital Information System (HIS), Laboratory Information System (LIS), Radiology Information System (RIS), Telemedicine and PACS Solutions apart from a range of hardware accessories. Trivitron is also looking at venturing into a few healthcare services and consultancy services to leverage its present strength, customer relationships and networks.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.